MedicineWatch US
Class II Recall

Teva Pharmaceuticals USA

Product
Epoprostenol Sodium for Injection, 1.5 mg/vial, 10 mL vials, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-1995-01
Reason
Lack of Assurance of Sterility
Classification
Class II
Status
Terminated
Lot
Lot #: 31329113B, exp. date 05/2022
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.